Both Annamycin dose arms outperformed control on the primary endpoint of complete remission (CR): 43% and 36% versus 12% — ...
Ondas's defense-tech roll-up surged 10x YoY on acquisitions and a $457M backlog, but dilution adds risk. See why I rate ONDS ...
The Islanders didn’t extend qualifying offers to any of their three NHL-level restricted free agents by Monday’s deadline, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results